» Authors » Ivan Kosalec

Ivan Kosalec

Explore the profile of Ivan Kosalec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 595
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gorski D, Vlainic J, Skrlec I, Novak S, Novosel Z, Biloglav Z, et al.
Microorganisms . 2024 Sep; 12(9). PMID: 39338482
and are opportunistic pathogens commonly found in the microbiota of humans and other animals as well as in the environment. This article presents the results of antimicrobial susceptibility testing using...
2.
Rogga V, Kosalec I
Arh Hig Rada Toksikol . 2023 Oct; 74(3):145-166. PMID: 37791675
Polymyxin antibiotics are the last resort for treating patients in intensive care units infected with multiple-resistant Gram-negative bacteria. Due to their polycationic structure, their mode of action is based on...
3.
Klaric D, Pocrnic M, Lez D, Polovic S, Kontrec D, Kosalec I, et al.
J Biol Inorg Chem . 2022 Oct; 27(8):715-729. PMID: 36220939
The in vitro antimicrobial activity of Fe(III) and Ga(III) complexes with N'-(2,3-dihydroxy-phenylmethylidene)-3-pyridinecarbohydrazide (HL), N'-(2,4-dihydroxy-phenyl-methylidene)-3-pyridinecarbohydrazide (HL), N'-(2,5-dihydroxy-phenylmethylidene)-3-pyridinecarbohydrazide (HL), N'-(2-hydroxy-3-methoxyphenyl-methylidene)-3-pyridine-carbohydrazide (HL), N'-(2-hydroxy-4-methoxyphenylmethyl-idene)-3-pyridine-carbohydrazide (HL), and N'-(2-hydroxy-5-methoxyphenylmethylidene)-3-pyridinecarbo-hydrazide (HL) toward several Gram-positive strains of Staphylococcus...
4.
Vukoja D, Vlainic J, Ljolic Bilic V, Martinaga L, Rezic I, Gorski D, et al.
Pharmaceutics . 2022 Aug; 14(8). PMID: 36015339
Growing morbidity and mortality rates due to increase in the number of infections caused by MDR (multi-drug resistant) microorganisms are becoming some of the foremost global health issues. Thus, the...
5.
Friscic M, Petlevski R, Kosalec I, Madunic J, Matulic M, Bucar F, et al.
Pharmaceuticals (Basel) . 2022 May; 15(5). PMID: 35631332
Species from the genus L. have been used as healing agents for various ailments, with utilization of L. being most frequently reported. The aim of this study was to evaluate...
6.
Ljoljic Bilic V, Gasic U, Milojkovic-Opsenica D, Rimac H, Vukovic Rodriguez J, Vlainic J, et al.
Antibiotics (Basel) . 2022 Apr; 11(4). PMID: 35453242
Followed by a buildup of its phytochemical profile, is being subjected to antimicrobial investigation guided with its ethnobotanical use. The results of performed in vitro screening on , , and...
7.
Kaskatepe B, Aslan Erdem S, Ozturk S, Oz Z, Subasi E, Koyuncu M, et al.
Molecules . 2022 Feb; 27(3). PMID: 35163928
The aim of this study was to investigate and compare in detail both the antifungal activity in vitro (with planktonic and biofilm-forming cells) and the essential oil composition (EOs) of...
8.
Suran J, Cepanec I, Masek T, Starcevic K, Tlak Gajger I, Vranjes M, et al.
Antioxidants (Basel) . 2021 Jul; 10(6). PMID: 34207316
We compared the chemical composition, antioxidant and antimicrobial activity of two propolis extracts: one obtained with nonaqueous polyethylene glycol, PEG 400 (PgEP), and the other obtained with ethanol (EEP) We...
9.
Vlainic J, Jovic O, Kosalec I, Vugrek O, coz-Rakovac R, Smuc T
Molecules . 2021 Jul; 26(12). PMID: 34201401
The limited number of medicinal products available to treat of fungal infections makes control of fungal pathogens problematic, especially since the number of fungal resistance incidents increases. Given the high...
10.
Rezic I, Majdak M, Ljoljic Bilic V, Pokrovac I, Martinaga L, Somogyi Skoc M, et al.
Polymers (Basel) . 2021 Mar; 13(4). PMID: 33672118
In this work the in vitro antimicrobial activity of colloidal solutions of nine different commercially available nanoparticles were investigated against strains, both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA). Research covered antimicrobial...